[Answered] Misrepresentation does not require proof of the buyer's reliance. Indicate whether the statement ...

This topic contains a solution. Click here to go to the answer

Author Question: Misrepresentation does not require proof of the buyer's reliance. Indicate whether the statement ... (Read 95 times)

jilianpiloj

Hero Member
Posts: 521

on: Jun 24, 2018

Misrepresentation does not require proof of the buyer's reliance.
Indicate whether the statement is true or false

Question 2

Cumulative preferred stock carries a guarantee of a dividend.
Indicate whether the statement is true or false

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

fauacakatahaias

Sr. Member
Posts: 353

Reply #1 on: Jun 24, 2018

Answer to Question 1

FALSE

Answer to Question 2

TRUE

jilianpiloj

Member
Posts: 521

Reply 2 on: Jun 24, 2018

Thanks for the timely response, appreciate it

upturnedfurball

Member
Posts: 334

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

Dogs have been used in studies to detect various cancers in human subjects. They have been trained to sniff breath samples from humans that were collected by having them breathe into special tubes. These people included 55 lung cancer patients, 31 breast cancer patients, and 83 cancer-free patients. The dogs detected 54 of the 55 lung cancer patients as having cancer, detected 28 of the 31 breast cancer patients, and gave only three false-positive results (detecting cancer in people who didn't have it).

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.